On Wednesday, Shares of MGM Resorts International (NYSE:MGM), gained 2.18% to $22.74.
Beau Rivage is a wholly owned partner of MGM Resorts International™ (MGM), one of the world’s leading global hospitality companies.
Beau Rivage Resort & Casino welcomes the holiday season with twinkling displays, exquisite shopping, and holiday charm throughout the property. The Gulf Coast’s premier resort will transform into a whimsical winter wonderland with a host of entertainment and special events the entire family can enjoy.
Guests will be enchanted throughout the season at one of the most anticipated holiday destinations in the South. On display through Jan. 4, stunning larger-than-life nutcrackers, magnificent oversized ornaments, frost-covered trees, classic winter scenes, and thousands of white and red poinsettias will adorn the 1,740-room resort and provide opportunities to create unforgettable memories.
“For more than a decade, Beau Rivage has captivated guests with its must-see displays, affordable family entertainment and holiday festivities,” said Beau Rivage General Manager Marcus Glover. “We look forward to spreading holiday cheer during one of the most joyful and beloved times of the year.”
The excitement of the season will come alive with Santa & Friends on Ice in the Beau Rivage Theatre Dec. 1-27. A frozen winter pond made of real ice will be featured for professional skaters and other performers. Santa Claus is joined by Mrs. Claus, his elves, and others as they mingle seasonal classics, such as “Jingle Bell Rock” and “Santa Claus is Coming to Town,” with modern routines. Designed to delight the young and old alike, these award-winning performers will captivate all audiences. Guests can enjoy a snowfall at every show. Tickets start at $12.95 plus tax and service charge. Show times are Tuesday-Friday 7:00 p.m. and Saturday-Sunday 3:00 p.m. and 7:00 p.
MGM Resorts International, through its auxiliaries, owns and/or operates casino resorts. It operates through two segments, Wholly Owned Domestic Resorts and MGM China. The company’s casino resorts offer gaming, hotel, convention, dining, entertainment, retail, and other resort amenities.
Shares of New Gold Inc. (USA) (NYSEMKT:NGD), inclined 3.72% to $2.23, during its last trading session.
New Gold Inc., provides an update on the company’s exploration success at the Peak Mines (“Peak”). The company’s 2015 exploration efforts have resulted in the discovery of two new zones of polymetallic mineralization, Chronos and Anjea, both located right away adjacent to current and past-producing ore deposits within Peak’s main nine-kilometre long mine corridor. Chronos is a zone of gold-silver-copper-lead-zinc mineralization located directly above the Perseverance ore body which is presently in production and adjacent to the Peak mill. Anjea is a zone of copper-gold-silver-lead-zinc mineralization located adjacent to the historic Great Cobar mine and about nine kilometres north of the Peak mill.
“We are very happy to have discovered two new zones of mineralization in such close proximity to our existing infrastructure,” stated Mark Petersen , Vice President Exploration. “It is rewarding to see a mine that has already delivered over twenty years of resource replacement continue to demonstrate such strong potential for new discoveries. We look forward to building further on the results at both Chronos and Anjea in addition to several newly emerging mineralized prospects between them.”
New Gold Inc., a gold mining company, engages in the acquisition, exploration, development, and operation of mineral properties. It primarily explores for gold, silver, and copper deposits.
Finally, Shares of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), ended its last trade with 2.20% gain, and closed at $61.27.
Teva Pharmaceutical Industries Ltd., will host a live audio webcast at the Jefferies Autumn 2015 Global Healthcare Conference. Eyal Desheh will present on Thursday, November 19, 2015 at 11:20 AM GMT.
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic, specialty, and other pharmaceutical products worldwide. The company operates in two segments, Generic Medicines and Specialty Medicines.
